The global macular degeneration treatment market size was valued at USD 10.06 billion in 2024 and it is projected to reach ...

Introduction The eye's macula is impacted by macular degeneration, a neurodegenerative condition. Macular degeneration will cause loss of centr ...

DelveInsight's 'Dry Age-Related Macular Degeneration Pipeline Insight 2025' report provides comprehensive global coverage of ...

People who are of European descent may be more at risk of age-related macular degeneration than those of African or Hispanic ...

In the last 20 years, there have been rapid advances in the treatment options ... patients with myopic macular degeneration complicated by CNV may benefit from a new ophthalmic frontier of ...

Lower rates of both progression of macular fibrosis and intravitreal aflibercept injections were found in those who used the ...

However, bevacizumab is not currently licensed for neovascular age-related macular degeneration (nAMD). Our study is the first trial-based ... Patients allocated to discontinuous treatment began a new ...

At a single academic tertiary referral center, mild intraocular inflammation developed in four eyes following intravitreal ...

Sitala Bio Ltd. has prepared new indole derivatives acting as complement factor B (CFB) inhibitors. They are thus reported to be useful for the treatment of age-related macular degeneration, ...

In this Healio Video Perspective from Retina 2025, Peter K. Kaiser, MD, of Ocular Therapeutix, discusses positive data for ...

SBL03 was formulated as an ophthalmic gel for non-invasive topical delivery. Its unique ability to infiltrate eye tissues effectively and protect ret ...

In October, Oxular began a phase 2 trial for its therapeutic candidate OXU-001, for treatment of diabetic macular edema ...